FDA approves Lumicell’s breast cancer imaging tool
Lumicell developed the technology to enable physicians to detect residual cancer in the breast cavity after surgery.
FDA approves Lumicell’s breast cancer imaging tool Read More »
Uncategorized
Exactech recalls shoulder devices after initially declining to act
After the FDA issued a public safety notice and sent Exactech a warning letter, the firm agreed to recall shoulder implants due to packaging issues.
Exactech recalls shoulder devices after initially declining to act Read More »
OAK 2000: Transformando El Paisaje Urbano de Barcelona
OAK 2000 es una compañía de construcción con sede en Barcelona, especializada en renovaciones. Siempre se ha caracterizado por su compromiso con la calidad artesanal y la innovación en el diseño, lo que le ha ganado una alta reputación en la indust …
OAK 2000: Transformando El Paisaje Urbano de Barcelona Read More »
Todo lo que sabemos sobre el iPhone 16: Novedades, mejoras y expectativas
Los rumores y filtraciones sobre el iPhone 16 han generado gran expectación entre los fanáticos de la tecnología y seguidores de Apple. Con cada lanzamiento, la marca busca innovar y ofrecer características distintas que marquen la diferencia respecto a generaciones anter …
Todo lo que sabemos sobre el iPhone 16: Novedades, mejoras y expectativas Read More »
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
Guardant Health, Inc. today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the company’s Shield™ blood test for colorectal cancer (CRC) screening on Thursday, May 23, 2024.
NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer’s Disease
NeuroSense Therapeutics Ltd. announced today a collaboration in Alzheimer’s Disease (AD) drug development with Genetika+ , a leader in precision medicine for psychiatry and neurology.
Chiesi Group’s 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices
In 2023, Chiesi, a research-oriented international biopharmaceutical group headquartered in Parma, with 31 affiliates worldwide, showcased the efficacy of its operating model centred around shared value, sustainability, and high ethical standards.
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer
Hyundai Bioscience announced the positive results from its preclinical study on triple-negative breast cancer, investigating combination therapy of ‘Niclosamide-based oral anti-cancer drug’ jointly developed with CNPharm and Docetaxel, one of widely-used chemical anticancer agents.
El futuro del Grupo Local de Galaxias
Nuestro hogar galáctico, conocido como el Grupo Local, se destaca como una colección fascinante de galaxias que incluye la Vía Láctea, Andrómeda y otras galaxias más pequeñas. Pero ¿qué nos depara el futuro para este grupo cósmico …
Trends in telehealth: Expanding the role of nurses in virtual care
Nurses will play an integral role as virtual care becomes a more widely adopted care model. But while virtual nursing care has the potential to enhance efficiency and reduce costs, it’s not without its challenges
Trends in telehealth: Expanding the role of nurses in virtual care Read More »